“The Overexpression of ABCG2 Reduces the Efficacy of Volasertib (BI 6727) and GSK641364 in Human S1-M1-80 Colon Carcinoma Cells” (2014) Journal of Cancer Research Updates, 3(2), pp.  108–116. doi:10.6000/1929-2279.2014.03.02.5.